drugset / Trial / NCT00017524
AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors
Phase 1
Completed
22 enrolled
University of Alabama at Birmingham
National Cancer Institute (NCI) · collab
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of AG2037 in treating patients who have advanced, metastatic, or recurrent solid tumors.
Timeline
- Start
- 2001-03
- Primary completion
- —
- Completion
- 2004-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PELITREXOL | Small molecule | — | Intravenous |